Stock Analysis tagged as

Sector - Healthcare and Social Assistance

  • Showing 1-100 of 150 items
  • 1
  • 2
  • >>
  1. 3 Nasdaq-100 Components at All-time Highs (AVGO, ISRG)

  2. Sectors ETFs to Avoid Right Now (XLF, XLE)

  3. Curb Your Enthusiasm With the Biotech Bounce

  4. 3 Plays for the Biotech Bear Market (GILD, UTHR)

  5. Overlooked Israel Is A Portfolio Growth Engine

  6. The Celtic Tiger Roars Once Again

  7. The REIT Play In Healthcare

  8. Valeant Eyes Bausch & Lomb

  9. Roche, Reloaded

  10. Elan Continues To Make Baffling Strategic Decision

  11. After A Big Rally, Pfizer Might Need Some Rest

  12. Adasuve Deal Is Very Good For Alexza, But What About Teva?

  13. Recent Financials May Not Be Entirely Fair To Hologic

  14. Amgen Chased By The Bubble

  15. Teva Still Too Cheap, But Still Too Uncertain

  16. It Gets A Little Harder From Here For Covidien

  17. Thermo Steps Up And Seals A Deal For Life Technologies

  18. Broad Weakness Makes It Harder To Like St. Jude Today

  19. Pharma Is Doing All The Pulling For Johnson & Johnson

  20. 4 ETFs To Play A Booming Healthcare Sector

  21. Pfizer Readies Zoetis For Market

  22. Herbalife Is Merely A Pawn In This Hedge Fund Battle Royal

  23. Abbott Labs Spins Off AbbVie: Which Is The Better Buy?

  24. A Look Back At The Year In Pharmaceuticals

  25. A Look Back At The Year In Medical Technology

  26. A Look Back At The Year In Biotech

  27. A Triple Play Of Biotech Disappointments Last Week

  28. How Far Can Philips' Turnaround Take The Stock?

  29. Smith & Nephew's Costly Deal

  30. Endo Health Solutions Needs Some Solutions Of Its Own

  31. Bayer Buys Schiff Nutrition International: Winners All Around

  32. Is “Less Bad” As Good As It Gets For Dendreon?

  33. Drugs Have Moved J&J On To A New Phase

  34. Danaher Does Another Typical Danaher Deal

  35. The Week In Healthcare

  36. Investor Unrest Leads The WellPoint CEO To Resign

  37. Pfizer Looks To Spin Off Animal Health Unit

  38. The Week Ahead In Healthcare

  39. The Week Ahead In Healthcare

  40. More Healthy Alternatives To Zimmer

  41. Hi-Tech Pharmacal An Under Followed Name Worth Following

  42. WellPoint Buys More Medicaid Exposure

  43. Lincare Shows That You Can Go Home Again

  44. Can Body Sculpting Bulk Up Solta Medical?

  45. Medicine Gets Personalized

  46. Bio-Reference Labs Taking Advantage Of Esoteric Opportunities

  47. Want A High-Yield Healthcare Stock? Look To Canada

  48. Stocks On Fire As The Market Bounces

  49. AmerisourceBergen Looks Very Healthy

  50. Lifepoint Hospitals Heads For The Country

  51. Becton Dickinson Safe And Steady

  52. Davita Goes Shopping

  53. Stocks That Keep You Looking Good

  54. Market-Crushing ETFs

  55. A Healthy Growth Strategy

  56. Control May Be Herbalife's Real Long-Term Problem

  57. Premium-Price athenahealth Leaves Little Room For Error

  58. Obagi Puts Its Problems Behind It

  59. Stocks Showing Resilience

  60. ilent Pays A Hefty Price For A Fixer-Upper Diagnostics Company

  61. Top Rated Highly Shorted Stocks

  62. AstraZeneca Searches For Answers

  63. LabCorp Fighting Industry Headwinds

  64. Healthcare Services Group - Great Business … Great Stock?

  65. Smart Stocks To Rally With

  66. A Strong Prognosis For Healthcare REITs

  67. Birth Control Subsidies Slashed: Will Big Pharma Take A Hit?

  68. Wall Street Isn't Buying The Medifast Story

  69. Stocks For An Uncertain World

  70. LabCorp Passes the Test

  71. Transcend Services: A Physician's Best Friend

  72. Pfizer Shrugs Off the Loss Of Lipitor

  73. 4 Overbought Stocks To Watch

  74. The Long-Term Play In Lab Work

  75. Europe Won't Kill Siemens

  76. Best S&P 500 Stocks Of 2011

  77. Slow And Steady ETFs Outperforming

  78. 4 Heavily Shorted Stocks That Could Climb Higher

  79. 4 ETFs On Fire Right Now

  80. The War Against Alzheimer's Requires Thinking Small

  81. 2011's Biggest Mergers and Acquisitions

  82. Neogen Is Almost Cheap

  83. How Intuitive Surgical Justifies Its Lofty Valuation

  84. 2011 - Another Sick Year For Larger Med-Tech

  85. 2011 In Review - Pharmaceuticals

  86. 2011 In Review - The Best-Performing ETFs

  87. Hill-Rom: Litigation Equals Opportunity For Investors

  88. Sanofi's Investment Prospects

  89. SonoSite Finds Its Deal

  90. Will Qiagen's Restructuring Address The Real Problems?

  91. Covidien Delivers Once Again

  92. Meridian Biosciences – Stealth Income Play

  93. Is Hologic A Coiled Spring?

  94. If CareFusion Can Execute, This Is A Major Bargain

  95. CVS Shows Its Resilience In Any Economy

  96. Biogen Idec Has Built A Valuable Franchise

  97. No Rattle At HUM

  98. Zimmer Looking To Escape Its Value Trap

  99. VCA Antech Cut Down To Value

  100. Stryker Scraping By

  • Showing 1-100 of 150 items
  • 1
  • 2
  • >>
Trading Center